SARAH SMITH: Open Payments
NPI 1215288584 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 18 payments from 9 companies in 2025. Trend: 2023 $368 · 2024 $280 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $110 |
| ABBVIE INC. | 5 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: QULIPTA, FARXIGA, VRAYLAR, AIRSUPRA, XIFAXAN, SHINGRIX, APTIMA, Veozah.
Industry payments across PA — which companies pay providers there.
